Pharma / Medical

Compounded medications are prepared as per the doctor’s prescription and formulated in the exact strength and form needed by the patient. This allows doctors and pharmacists to customize a medication that meets the patient’s specific requirements. Historically, all medicines were compounded, but with mass-produced drugs this is no longer the case. A ‘one-size-fits-all’ approach does not, however, always meet the needs of patients, and compounding pharmacists provide a solution for this. Modern technology and innovation has revived the historic art and science of compounding pharmaceuticals. The Fagron compounding pharmacies in Cape Town (Rausa-kem), Johannesburg (Dynaceuticals) and George (Mar-Kem) have served doctors and patients since 1995. Fagron South Africa is well established as a respected partner and leader in the pharmaceutical compounding industry. Fagron entered the South African market through acquisition of key compounding pharmacies in Cape Town, George and Johannesburg. In 2014, Fagron acquired Dynaceuticals, a compounding pharmacy in Gauteng, which is headed by three dynamic professionals. In 2015, Fagron acquired Rausa-kem, which is headed by Professor Reinhard Uebel with 20 years of sterile compounding experience, Reakiri, the marketing and sales arm of Rausa-kem, and MarKem, a sterile compounding pharmacy in George. This powerful combination has created a unique, national organisation serving both doctors and patients all over the country. Our team of pharmacists is headed by Professor Reinhard Uebel, who graduated with a BPharm in 1982 and completed his PhD in 1994. He lectured pharmacology at the University of Stellenbosch and Pharmaceutics at UWC. Professor Uebel is the author of a number of research publications. Fagron South Africa compounds high-quality, cost-effective, customised, proven formulations of medications that are not available from a pharmaceutical drug company.

Key Oncologics (Pty) Ltd is a South African pharmaceutical company that primarily focuses on the treatment of cancer and allied diseases. The company was founded in 1998 representing international companies that do not have an independent presence in South Africa. Over the years our product profile has grown from a single product to a comprehensive portfolio. We have also diversified into biologics and are in the process of building a generic portfolio. In moving forward Key Oncologics will continue to seek options for patients to live longer and live better. Key Oncologics (Pty) Ltd has experience in registering, marketing, selling and distributing cancer products in the South African market. We also have a clinical trial division with the necessary infrastructure to conduct Oncology Clinical Trials according to GCP.

Hersol Manufacturing Laboratories is a fully licensed and registered pharmaceutical manufacturing company and was founded in 1980. Today Hersol is one of the leading Pharmaceutical Contract Manufacturing Companies within the South African Market. Hersol specialises in the development and manufacture of Complementary Medicines, Nutritional Supplements and Pharmaceuticals. Hersol prides itself on producing quality products through a carefully managed Total Quality Management System governing all activities, especially so as to lead the way in the Complementary Medicines and Nutritional Supplement market. As a result of the integrated Total Quality Management system, embracing first and foremost, Good Manufacturing Practices (GMP) and strict Quality Control Procedures, the best quality of both raw materials and finished product is ensured. This facility complies with the Medicine Control Council (MCC) Code of Good Manufacturing Practice (GMP), a standard of manufacturing excellence recognized throughout the Industry. Hersol maintains a watchful eye on world trends and then improves and innovates to deliver leading edge products to its customer base. This intimate market knowledge is gained through regular travel by Hersol’s Management team to major world markets. The company has acquired a reputation for consistent good quality, price, service and delivery, which is indicated by the fact that we hold a full pharmaceutical manufacturing license, which is re-assessed regularly by the South African Medicine Control Council. With Hersol manufacturing large volumes of supplements the R & D (Research and Development) department is an important contributor of new ideas and concepts that potentially add value to customers’ businesses. Close collaboration with raw material suppliers ensures that the very latest and highest quality ingredients are available for incorporation into prototype formulations, further adding value to the supply chain.

To ensure achievement of set operational objectives and to ensure desired business growth. Our current business is unified, adopting the traditional sales & marketing management styles. Embedded in this structure are Pharmaceutical and Veterinary business arms structured into territorial markets for ease of management and control. The Nigerian market and ECOWAS markets are thus similarly structured into districts and regions where Neimeth’s products are distributed. The Pharmaceuticals business distributes: Ethical Products – comprising of Neimeth branded ethical products including our flagship home grown product CIKLAVIT for the management of sickle cell disease. In addition products such as Normoretic, flexodene, Tiocosid, etc and new branded generics are part of the portfolio. Consumer Product – comprising 15 major product groups divided into 39 presentations. High volume products like NCP, Pyrantrin, Obron – 6, Homtamin G and Pancemol are included as part of consumer products portfolio. Veterinary Business  Neimeth is now poised to re-enter the lucrative Nigerian Animal Health business, which has very robust volume and profit potentials. We expect to regain a controlling market share in a few years. We have introduced our own brand of poultry and large animal range of anthelmintics, as well as production enhancing medicaments. We will also enter into strategic alliances in key disease areas that show great business potentials. Ecowas Business Neimeth is firmly on ground in the Anglophone West African Countries of Ghana, Sierra Leone, Liberia and the Gambia. Our key products like Ciklavit, Homtamin G, NCP have been registered there and are in rising demand. Before the brand name Neimeth International Pharmaceuticals Plc.,the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms. During the 40 year period (1957-1997), the company established the first pharmaceutical manufacturing plant in Nigeria at Aba, which was destroyed during the Nigerian civil war. It then set up and opened the most modern pharmaceutical plant in the West African sub-region in 1976 at Oregun, Lagos. These represent great milestones for a company that started as a trading venture in 1957 at a location in Ebute Metta, Lagos. We are committed to providing the opportunity for leadership at all levels on our organization, the pharmaceutical industry and indeed the Nation.

Reals Group started as Reals Pharmaceuticals Limited, a company that commenced its operation as the local scientific and marketing office of Zeneca Pharmaceuticals Limited, now AstraZeneca U.K. Today, the scope of our operations has extended beyond just being the local scientific and marketing office for AstraZeneca to becoming the sole Nigeria representative and distributor of a number of other first class pharmaceutical industries in the world. Reals Pharmaceuticals Limited was one of the first pharmaceutical companies to successfully commence the local scientific and marketing office in Nigeria. In 1996, the idea of scientific and marketing office was new to the pharmaceutical industry. It nevertheless required creative thinking, determination, courage and patience to implement. The company was incorporated as a limited liability company in August 1995. It started operations on January 2nd 1996, with a team of six, comprising of the General Manager, Pharm, Ade Popoola and five medical representatives. The new millennium has come with its various challenges, one of which is the very dynamic business environment. To meet these challenges, the group has gone into strategic alliance with some companies both within and outside Nigeria for contract manufacturing arrangement to manufacture REALS range of ethical and consumer healthcare pharmaceutical brands. On October 10th 2008 the group relocated to its own purposely built corporate headquarters, REALS PLAZA, located at Plot 1 Junaid Dosunmu Street, Central Business District, Alausa, Ikeja, Lagos. Hitherto, its head office was situated at All Seasons Plaza, Agidingbi, Ikeja. Reals group is a very relevant and active player in the Nigerian very competitive pharmaceutical market, possessing both spread and reach in the very vast and fertile Nigerian business terrain. Our sales and medical representatives are spread across all the six geo-political zones that make up the nation Nigeria.